溶解性 | DMSO 61 mg/mL Water <1 mg/mL Ethanol 8 mg/mL |
存贮条件 | 储存温度-20°C |
备注 | TAK-700 (Orteronel) is a potent and highly selective human 17,20-lyase inhibitor with IC50 of 38 nM, exhibits >1000-fold selectivity over other CYPs (e.g. 11-hydroxylase and CYP3A4). Phase 3. |
生化机理 | TAK-700 is an oral, selective, non-steroidal androgen synthesis inhibitor of the 17,20 lyase, which is a key enzyme in the production of steroidal hormones. In preclinical studies, TAK-700 has been shown to bind to and inhibit the enzyme 17,20 lygase in both the testes and adrenal glands. TAK-700 is currently under clinical Phase III studies. |
别名 | (S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-e]imidazol-7-yl)-N-methyl-2-naphthamide;(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-e]imidazol-7-yl)-N-methyl-2-naphthamide |
TAK-700 (Orteronel),抑制剂
TAK-700 (Orteronel) (订货以英文为准)
编号:T126788
CAS号:426219-18-3
分子式:C18H17N3O2
分子量:307.35
产品名称 | TAK-700 (Orteronel) |
中文名称 | TAK-700 (Orteronel),抑制剂 |
CAS号 | 426219-18-3 |
分子式(M.F.) | C18H17N3O2 |
分子量(M.W.) | 307.35 |
储存条件 | -20°C储存 |
标识符号 | https://www.aladdin-e.com/images/ghs/ghs07.jpg |
信号词 | Warning |
危害声明 | H315-H319-H335 |
警示性声明 | P261-P305 + P351 + P338 |
个人防护设备 | dust mask type N95 (US), Eyeshields, Gloves |
RTECS | UY5749237 |
WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品